Captello Appoints Nassir Jamal as New Chief Technology Officer
January 21, 2025 - 16:53
Captello is excited to announce the appointment of Nassir Jamal as its new Chief Technology Officer. With a wealth of experience in technology leadership and a proven track record in driving innovation, Jamal is set to play a pivotal role in advancing Captello's mission to provide cutting-edge lead capture and engagement solutions.
Jamal brings over 15 years of experience in the tech industry, having held various leadership positions in both startups and established companies. His expertise spans software development, system architecture, and product management, making him an ideal fit for Captello's ambitious growth plans.
In his new role, Jamal will be responsible for overseeing the company’s technological strategy and ensuring that Captello remains at the forefront of industry advancements. His leadership is expected to enhance the company's product offerings and improve customer engagement through innovative technology solutions.
The team at Captello is eager to leverage Jamal's insights and experience as they continue to expand their services and enhance their platform for clients worldwide.
MORE NEWS
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...